Frontiers in Oncology (Feb 2022)

CD38: A Significant Regulator of Macrophage Function

  • Wentao Li,
  • Wentao Li,
  • Yanling Li,
  • Xi Jin,
  • Xi Jin,
  • Qianjin Liao,
  • Zhifang Chen,
  • Honghua Peng,
  • Yanhong Zhou,
  • Yanhong Zhou

DOI
https://doi.org/10.3389/fonc.2022.775649
Journal volume & issue
Vol. 12

Abstract

Read online

Cluster of differentiation 38 (CD38) is a cell surface glycoprotein and multifunctional extracellular enzyme. As a NADase, CD38 produces adenosine through the adenosine energy pathway to cause immunosuppression. As a cell surface receptor, CD38 is necessary for immune cell activation and proliferation. The aggregation and polarization of macrophages are affected by the knockout of CD38. Intracellular NAD+ levels are reduced by nuclear receptor liver X receptor-alpha (LXR) agonists in a CD38-dependent manner, thereby reducing the infection of macrophages. Previous studies suggested that CD38 plays an important role in the regulation of macrophage function. Therefore, as a new marker of macrophages, the effect of CD38 on macrophage proliferation, polarization and function; its possible mechanism; the relationship between the expression level of CD38 on macrophage surfaces and disease diagnosis, treatment, etc; and the role of targeting CD38 in macrophage-related diseases are reviewed in this paper to provide a theoretical basis for a comprehensive understanding of the relationship between CD38 and macrophages.

Keywords